Electron spin resonance in the SS=1/2 quasi-one-dimensional antiferromagnet with Dzyaloshinskii-Moriya interaction BaCu2_2Ge2_2O7_7

We have investigated the electron spin resonance (ESR) on single crystals of BaCu$_2$Ge$_2$O$_7$ at temperatures between 300 and 2 K and in a large frequency band, 9.6 -134 GHz, in order to test the predictions of a recent theory, proposed by Oshikawa and Affleck (OA), which describes the ESR in a $S$=1/2 Heisenberg chain with the Dzyaloshinskii-Moriya interaction. We find, in particular, that the ESR linewidth, $\Delta H$, displays a rich temperature behavior. As the temperature decreases from $T_{max}/2\approx$ 170 K to 50 K, $\Delta H$ shows a rapid and linear decrease, $\Delta H \sim T$. At low temperatures, below 50 K, $\Delta H$ acquires a strong dependence on the magnetic field orientation and for $H \| c$ it shows a $(h/T)^2$ behavior which is due to an induced staggered field $h$, according to OA's prediction

Magnetic anisotropy in epitaxial Mn5Ge3 films

High crystalline quality Mn 5 Ge 3 films with thicknesses ranging 4–200 nm have been grown on Ge(111) substrates by solid phase epitaxy. The basal hexagonal plane of Mn 5 Ge 3 is in epitaxy with the Ge(111) plane. Magnetic properties of the films have been investigated as a function of the film thickness and the magnetization curves have been analyzed using a theory that includes a description of magnetic domains in uniaxial thin films. The results clearly indicate the existence of a critical thickness below which the magnetic stripe phase disappears. We have determined the value of this thickness to lie between 10 and 25 nm from the analysis of experimental magnetization curves and the theoretical fit of the in-plane remanent magnetization. Although analogies can be drawn between the behavior observed in our system and that of hcp Co, we have shown that the critical thickness is considerably smaller in Mn 5 Ge 3 ; this has the potential to open new fields of applications for Mn 5 Ge 3 thin films in magnetic recording and spintronics

Cross-relaxation and phonon bottleneck effects on magnetization dynamics in LiYF4:Ho3+

Frequency and dc magnetic field dependences of dynamic susceptibility in diluted paramagnets LiYF$_4$:Ho$^{3+}$ have been measured at liquid helium temperatures in the ac and dc magnetic fields parallel to the symmetry axis of a tetragonal crystal lattice. Experimental data are analyzed in the framework of microscopic theory of relaxation rates in the manifold of 24 electron-nuclear sublevels of the lowest non-Kramers doublet and the first excited singlet in the Ho$^{3+}$ ground multiplet $^5I_8$ split by the crystal field of S$_4$ symmetry. The one-phonon transition probabilities were computed using electron-phonon coupling constants calculated in the framework of exchange charge model and were checked by optical piezospectroscopic measurements. The specific features observed in field dependences of the in- and out-of-phase susceptibilities (humps and dips, respectively) at the crossings (anti-crossings) of the electron-nuclear sublevels are well reproduced by simulations when the phonon bottleneck effect and the cross-spin relaxation are taken into account

Quantum Monte Carlo study of a resonant Bose-Fermi mixture

We study resonant Bose-Fermi mixtures at zero temperature, with different relative concentrations of the bosons. We use for the first time a Quantum Monte Carlo method with Fixed-Node approxima- tion, to explore the system from the weak to the strong coupling limit. A repulsive interaction among bosons is introduced to provide stability to the bosonic component. Beyond the unitarity limit, the res- onant attractive interaction supports a bound fermionic dimer. At the many-body level, increasing the boson-fermion coupling the system undergoes a quantum phase transition from a state with condensed bosons immersed in a Fermi sea, to a normal Fermi-Fermi mixture of the composite fermions and the bare fermions in excess. We obtain the equation of state and we characterize the momentum distributions both in the weakly and in the strongly interacting limits. We compare Quantum Monte Carlo results to T-matrix calculations, finding interesting signatures of the different many-body ground states

Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): A randomised controlled trial.

BACKGROUND: The early use of broad-spectrum antibiotics remains the cornerstone for the treatment of neonatal late onset sepsis (LOS). However, which antibiotics should be used is still debatable, as relevant studies were conducted more than 20 years ago, recruited in single centres or countries, evaluated antibiotics not in clinical use anymore and had variable inclusion/exclusion criteria and outcome measures. Moreover, antibiotic-resistant bacteria have become a major problem in many countries worldwide. We hypothesized that efficacy of meropenem as a broad-spectrum antibiotic is superior to standard of care regimens (SOC) in empiric treatment of LOS and aimed to compare meropenem to SOC in infants aged 44 weeks meeting the Goldstein criteria of sepsis, were randomized in a 1:1 ratio to receive meropenem or one of the two SOC regimens (ampicillin+gentamicin or cefotaxime+gentamicin) chosen by each site prior to the start of the study for 8-14 days. The primary outcome was treatment success (survival, no modification of allocated therapy, resolution/improvement of clinical and laboratory markers, no need of additional antibiotics and presumed/confirmed eradication of pathogens) at test-of-cure visit (TOC) in full analysis set. Stool samples were tested at baseline and Day 28 for meropenem-resistant Gram-negative organisms (CRGNO). The primary analysis was performed in all randomised patients and in patients with culture confirmed LOS. Proportions of participants with successful outcome were compared by using a logistic regression model adjusted for the stratification factors. From September 3, 2012 to November 30th 2014, total of 136 patients (instead of planned 275) in each arm were randomized; 140 (52%) were culture positive. Successful outcome at TOC was achieved in 44/136 (32%) in the meropenem arm vs. 31/135 (23%) in the SOC arm (p = 0.087). The respective numbers in patients with positive cultures were 17/63 (27%) vs. 10/77 (13%) (p = 0.022). The main reason of failure was modification of allocated therapy. Treatment emergent adverse events occurred in 72% and serious adverse events in 17% of patients, the Day 28 mortality was 6%. Cumulative acquisition of CRGNO by Day 28 occurred in 4% of patients in the meropenem and 12% in the SOC arm (p = 0.052). CONCLUSIONS: Within this study population, we found no evidence that meropenem was superior to SOC in terms of success at TOC, short term hearing disturbances, safety or mortality were similar in both treatment arms but the study was underpowered to detect the planned effect. Meropenem treatment did not select for colonization with CRGNOs. We suggest that meropenem as broad-spectrum antibiotic should be reserved for neonates who are more likely to have Gram-negative LOS, especially in NICUs where microorganisms producing extended spectrum- and AmpC type beta-lactamases are circulating

Unrelated donor vs HLA-haploidentical a/b T-cell- and B-cell-depleted HSCT in children with acute leukemia

Traditionally, hematopoietic stem cell transplantation (HSCT) from both HLA-matched related and unrelated donors (UD) has been used for treating children with acute leukemia (AL) in need of an allograft. Recently, HLA-haploidentical HSCT after ab T-cell/B-cell depletion (abhaplo-HSCT) was shown to be effective in single-center studies. Here, we report the first multicenter retrospective analysis of 127 matched UD (MUD), 118 mismatched UD (MMUD), and 98 abhaplo-HSCT recipients, transplanted between 2010 and 2015, in 13 Italian centers. All these AL children were transplanted in morphological remission after a myeloablative conditioning regimen. Graft failure occurred in 2% each of UD-HSCT and abhaplo-HSCT groups. In MUD vs MMUD-HSCT recipients, the cumulative incidence of grade II to IV and grade III to IV acute graft-versus-host disease (GVHD) was 35% vs 44% and 6% vs 18%, respectively, compared with 16% and 0% in abhaplo-HSCT recipients (P < .001). Children treated with abhaplo-HSCT also had a significantly lower incidence of overall and extensive chronic GVHD (P < .01). Eight (6%) MUD, 32 (28%) MMUD, and 9 (9%) abhaplo-HSCT patients died of transplant-related complications. With a median follow-up of 3.3 years, the 5-year probability of leukemia-free survival in the 3 groups was 67%, 55%, and 62%, respectively. In the 3 groups, chronic GVHD-free/relapse-free (GRFS) probability of survival was 61%, 34%, and 58%, respectively (P < .001). When compared with patients given MMUD-HSCT, abhaplo-HSCT recipients had a lower cumulative incidence of nonrelapse mortality and a better GRFS (P < .001). These data indicate that abhaplo-HSCT is a suitable therapeutic option for children with AL in need of transplantation, especially when an allele-matched UD is not available

Decay of Rabi oscillations induced by magnetic dipole interactions in diluted paramagnetic solids

Decay of Rabi oscillations of equivalent spins diluted in diamagnetic solid matrix and coupled by magnetic dipole interactions is studied. It is shown that these interactions result in random shifts of spin transient nutation frequencies and thus lead to the decay of the transient signal. Averaging over random spatial distribution of spins within the solid and over their spectral positions within magnetic resonance line, we obtain analytical expressions for the decay of Rabi oscillations. The rate of the decay in the case when the half-width of magnetic resonance line exceeds Rabi frequency is found to depend on the intensity of resonant microwave field and on the spin concentration. The results are compared with the literature data for E1' centers in glassy silica and [AlO4] centers in quartz.Comment: 14 pages, 3 figure